Calprotectin as a Biomarker for Rheumatoid Arthritis: A Systematic Review

@article{Abildtrup2015CalprotectinAA,
  title={Calprotectin as a Biomarker for Rheumatoid Arthritis: A Systematic Review},
  author={Mads Abildtrup and G. Kingsley and D. Scott},
  journal={The Journal of Rheumatology},
  year={2015},
  volume={42},
  pages={760 - 770}
}
  • Mads Abildtrup, G. Kingsley, D. Scott
  • Published 2015
  • Medicine
  • The Journal of Rheumatology
    • Objective. Calprotectin (myeloid-related protein 8/14), a heterodimeric complex of calcium-binding proteins, is expressed in granulocytes and monocytes. Calprotectin levels are high in synovial tissue, particularly in activated cells adjacent to the cartilage-pannus junction. This systematic review evaluates the use of calprotectin as an indicator of disease activity, therapeutic response, and prognosis in rheumatoid arthritis (RA). Methods. Medline, Scopus, and the Cochrane Library (1970–2013… CONTINUE READING
    View on Publisher
    ncbi.nlm.nih.gov
    55 Citations
    Highly Influential Citations
    3
    Background Citations
    21
    Methods Citations
    2
    Results Citations
    2

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    55 Citations
    Citation Type

    Citation Type

    Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis
    • 14
    • Highly Influenced
    Calprotectin in patients with chronic rheumatoid arthritis correlates with disease activity and responsiveness to methotrexate
    • 7
    The Role of Calprotectin in Rheumatoid Arthritis
    • 1
    • Highly Influenced
    • PDF
    Systemic calprotectin and chronic inflammatory rheumatic diseases.
    • 7
    Evaluation of Serum Calprotectin Level and Disease Activity in Patients with Rheumatoid Arthritis.
    • 1
    Pre-analytical and analytical confounders of serum calprotectin as a biomarker in rheumatoid arthritis
    • 1
    Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
    • 1
    Association of circulating calprotectin with lipid profile in axial spondyloarthritis
    • 4
    • PDF
    Synovial calprotectin: A POTENTIAL BIOMARKER TO EXCLUDE A PROSTHETIC JOINT INFECTION
    • 23
    Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis
    • 10

    References

    SHOWING 1-10 OF 54 REFERENCES
    Calprotectin in Rheumatoid Arthritis
    • 37
    Leukocyte protein calprotectin and outcome in rheumatoid arthritis
    • 41
    Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis
    • 93
    Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis
    • 110
    Calprotectin (a major leucocyte protein) is associated with the levels of anti‐CCP and rheumatoid factor in a longitudinal study of patients with very early rheumatoid arthritis
    • 24
    Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity.
    • 70
    The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab
    • 55
    Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases.
    • 126
    The major leukocyte protein L1 as an indicator of inflammatory joint disease.
    • 36
    Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis
    • 57